Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05651945 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

Study acronym: SRP-CROSS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jan 20, 2027 → Jan 20, 2028
See other at-risk trials from Hackensack Meridian Health

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jan 20, 2027 to Jan 20, 2028v12
  2. Primary completion date: Jan 20, 2026 to Jan 20, 2027v11
  3. Re-verified, no change to tracked fieldsv10
  4. Enrollment target: 112 to 150v9
  5. 2 versions Re-verified since Jul 8, 2024, no change to tracked fieldsv7-v8
Show 5 earlier versionsHide 5 earlier versions
  1. Secondary endpoints: 12 to 13v6
  2. Eligibility criteria shortened, about 22 wordsv5
  3. Eligibility criteria expanded, about 13 wordsv4
  4. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jan 3, 2026 to Jan 20, 2026
    • Study completion date: Jan 3, 2031 to Jan 20, 2031
    • Start date changed from estimate of Jan 3, 2023 to Jan 20, 2023
    • Site details revised
  5. Collaborators expanded, about 13 words
    • Study title expanded, about 2 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.
Trial Details
NCT Number NCT05651945
Lead Sponsor Hackensack Meridian Health
Collaborators: The Cardiovascular Institute of New Jersey at Rutgers Robert Wood Johnson Medical School
Conditions
(from sponsor)		 Stroke, Cerebrovascular Accident
Related terms Cardiovascular Diseases, Motor Activity, Stroke
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov